Alkermes buys pulmonary drug system manufacturer AIR (Advanced Inhalation Research)
This article was originally published in Clinica
Executive Summary
Drug delivery company Alkermes has bought the privately-held Advanced Inhalation Research (AIR), which develops dry-powder pulmonary drug delivery systems, in a share transaction valued at around $115 million.